Found: 10
Select item for more details and to access through your institution.
Bacterial coinfections in dengue virus disease: what we know and what is still obscure about an emerging concern.
- Published in:
- Infection, 2017, v. 45, n. 1, p. 1, doi. 10.1007/s15010-016-0927-6
- By:
- Publication type:
- Article
New Macrocyclic Amines Showing Activity as HIV Entry Inhibitors Against Wild Type and Multi-Drug Resistant Viruses.
- Published in:
- Molecules, 2009, v. 14, n. 5, p. 1927, doi. 10.3390/molecules14051927
- By:
- Publication type:
- Article
Incidence, Risk Factors and Impact on Clinical Outcomes of Bloodstream Infections in Patients Hospitalised with COVID-19: A Prospective Cohort Study.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 9, p. 1031, doi. 10.3390/antibiotics10091031
- By:
- Publication type:
- Article
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19.
- Published in:
- Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040550
- By:
- Publication type:
- Article
Three case reports of West Nile virus neuroinvasive disease: lessons from real-life clinical practice.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriers.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 9, p. 2236, doi. 10.1093/jac/dks175
- By:
- Publication type:
- Article
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 1, p. 192, doi. 10.1093/jac/dkq384
- By:
- Publication type:
- Article
Analysis of protease inhibitor combinations in vitro: activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population.
- Published in:
- BMC Infectious Diseases, 2012, v. 12, n. 1, p. 179, doi. 10.1186/1471-2334-12-179
- By:
- Publication type:
- Article
Impact of daily versus weekly service of infectious diseases consultation on hospital antimicrobial consumption: a retrospective study.
- Published in:
- 2020
- By:
- Publication type:
- journal article